Atnaujinkite slapukų nuostatas

Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness [Minkštas viršelis]

  • Formatas: Paperback / softback, 304 pages, aukštis x plotis: 229x152 mm
  • Išleidimo metai: 16-Apr-2015
  • Leidėjas: National Academies Press
  • ISBN-10: 0309316898
  • ISBN-13: 9780309316897
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 304 pages, aukštis x plotis: 229x152 mm
  • Išleidimo metai: 16-Apr-2015
  • Leidėjas: National Academies Press
  • ISBN-10: 0309316898
  • ISBN-13: 9780309316897
Kitos knygos pagal šią temą:
Myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) are serious, debilitating conditions that affect millions of people in the United States and around the world. ME/CFS can cause significant impairment and disability. Despite substantial efforts by researchers to better understand ME/CFS, there is no known cause or effective treatment. Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made. Some health care providers have been skeptical about the serious physiological - rather than psychological - nature of the illness. Once diagnosed, patients often complain of receiving hostility from their health care provider as well as being subjected to treatment strategies that exacerbate their symptoms.



Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS and a new term for the illness - systemic exertion intolerance disease(SEID). According to this report, the term myalgic encephalomyelitis does not accurately describe this illness, and the term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome stresses that SEID is a medical - not a psychiatric or psychological - illness. This report lists the major symptoms of SEID and recommends a diagnostic process.One of the report's most important conclusions is that a thorough history, physical examination, and targeted work-up are necessary and often sufficient for diagnosis. The new criteria will allow a large percentage of undiagnosed patients to receive an accurate diagnosis and appropriate care.



Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be a valuable resource to promote the prompt diagnosis of patients with this complex, multisystem, and often devastating disorder; enhance public understanding; and provide a firm foundation for future improvements in diagnosis and treatment.

Table of Contents



Front Matter Summary 1 Introduction 2 Background 3 Current Case Definitions and Diagnostic Criteria, Terminology, and Symptom Constructs and Clusters 4 Review of the Evidence on Major ME/CFS Symptoms and Manifestations 5 Review of the Evidence on Other ME/CFS Symptoms and Manifestations 6 Pediatric ME/CFS 7 Recommendations 8 Dissemination Strategy Appendix A: Public Session Agendas Appendix B: GRADE Grid Template Appendix C: Disability in ME/CFS Appendix D: Questionnaires and Tools That May Be Useful for Assessing ME/CFS Symptoms Appendix E: Biographical Sketches of Committee Members, Consultants, and Staff
Preface xv
Acronyms And Abbreviations xvii
Summary 1(14)
1 Introduction
15(12)
Charge to the Committee
16(1)
Context for This Study
17(2)
The Committee's Approach
19(5)
Overview of the Report
24(1)
References
25(2)
2 Background
27(10)
History of ME/CFS
27(2)
Terminology
29(2)
Burden of ME/CFS
31(2)
References
33(4)
3 Current Case Definitions And Diagnostic Criteria, Terminology, And Symptom Constructs And Clusters
37(34)
Case Definitions and Diagnostic Criteria
38(19)
Terminology
57(3)
Symptom Constructs and Clusters
60(6)
References
66(5)
4 Review of the Evidence on Major Me/Cfs Symptoms and Manifestations
71(70)
Limitations of the Research Base
71(2)
Fatigue and Its Impact on Function
73(5)
Post-Exertional Malaise (PEM)
78(8)
Sleep-Related Symptoms
86(10)
Neurocognitive Manifestations
96(11)
Orthostatic Intolerance and Autonomic Dysfunction
107(12)
References
119(22)
5 Review of the Evidence on Other Me/Cfs Symptoms and Manifestations
141(40)
Pain
141(6)
Immune Impairment
147(5)
Neuroendocrine Manifestations
152(5)
Infection
157(5)
References
162(19)
6 Pediatric Me/Cfs
181(28)
Post-Exertional Malaise (PEM)
184(1)
Orthostatic Intolerance and Autonomic Dysfunction
185(4)
Neurocognitive Manifestations
189(1)
Sleep-Related Symptoms
190(1)
Infection
191(2)
Immune Impairment
193(2)
Neuroendocrine Manifestations
195(3)
Other Symptoms
198(1)
Symptom Constructs
199(1)
Summary
200(1)
References
201(8)
7 Recommendations
209(22)
Making the Diagnosis
213(12)
Disseminating the Diagnostic Criteria
225(1)
Updating the Diagnostic Criteria
226(1)
Naming the Disorder
227(1)
Closing Thoughts
228(1)
References
228(3)
8 Dissemination Strategy
231(18)
Objective
231(1)
Context
231(4)
Strategic Choices
235(4)
Dissemination Activities
239(7)
Evaluation
246(1)
References
246(3)
APPENDIXES
A Public Session Agendas
249(4)
B Grade Grid Template
253(4)
C Disability in Me/Cfs
257(12)
D Questionnaires and Tools That May Be Useful for Assessing Me/Cfs Symptoms
269(4)
E Biographical Sketches of Committee Members, Consultants, and Staff
273